Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

Healthcare Cannabis
FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is... see more

Recent & Breaking News (CSE:HUGE)

InvestmentPitch Media Video Discusses FSD Pharma's Sale of its 12% Interest in Cannara Biotech Generating 670% Return and $7.7 million in Proceeds - Video Available on Investmentpitch.com

Newsfile February 24, 2020

FSD Pharma Generates $7.7 Million in Proceeds and 670% Return on Investment through Sale of Interest in Cannara Biotech

Business Wire February 20, 2020

FSD Pharma CEO, Dr. Raza Bokhari, Discusses 2020 Goals with The Stock Day Podcast

Newsfile February 11, 2020

FSD Pharma Chairman & CEO to Present at 22nd Annual BIO CEO & Investor Conference in NYC

Canada NewsWire February 5, 2020

FSD Pharma Chairman & CEO to Present at 22nd Annual BIO CEO & Investor Conference in NYC

Business Wire February 5, 2020

FSD Pharma and Solarvest Enhance Commitment to CBD Research Project

Business Wire February 4, 2020

FSD Pharma and Solarvest Enhance Commitment to CBD Research Project

Canada NewsWire February 4, 2020

Seasoned Healthcare Executive and Academic Luminary Larry Kaiser, MD, Joins FSD Pharma Board of Directors

Business Wire January 22, 2020

FSD Pharma to Ring Nasdaq Opening Bell on Wednesday, January 22, 2020

Business Wire January 17, 2020

Welcome to the Big Leagues: FSD Up-Lists to the NASDAQ

Jonathon Brown January 14, 2020

Zacks Research: FSD Debuts on the NASDAQ

Featured Submission January 13, 2020

InvestmentPitch Media Video Discusses FSD Pharma's New Listing on the Nasdaq Capital Market and Upcoming Biotech and Healthcare Conferences - Video Available on Investmentpitch.com

Newsfile January 10, 2020

The StockTalk Cannabis Report: Jan. 10, 2020

Dave Jackson January 10, 2020

FSD Pharma to Commence Trading on Nasdaq Capital Market Under Symbol 'HUGE'

Canada NewsWire January 9, 2020

FSD Pharma to Commence Trading on Nasdaq Capital Market Under Symbol 'HUGE'

Business Wire January 9, 2020

FSD Pharma gears up for new NASDAQ listing

Stockhouse Editorial January 6, 2020

FSD Pharma to Begin Trading on the NASDAQ Capital Market Under Symbol 'HUGE' on January 9, 2020

Business Wire January 6, 2020

FSD Pharma to Begin Trading on the NASDAQ Capital Market Under Symbol 'HUGE' on January 9, 2020

Canada NewsWire January 6, 2020

FSD Pharma Strengthens Management Team

Business Wire January 2, 2020

FSD Pharma Strengthens Management Team

Canada NewsWire January 2, 2020